Tirtha Chakraborty
Hoofd Techniek/Wetenschap/O&O bij VOR BIOPHARMA INC.
Vermogen: 304 696 $ op 30-04-2024
Actieve functies van Tirtha Chakraborty
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VOR BIOPHARMA INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2020 | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Consultant / Adviseur | 24-07-2023 | - |
Loopbaan van Tirtha Chakraborty
Eerdere bekende functies van Tirtha Chakraborty
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01-10-2018 | 01-10-2019 |
| CRISPR THERAPEUTICS AG | Directeur/Bestuurslid | 01-01-2015 | 01-10-2018 |
| Corporate Officer/Principal | 01-01-2015 | 01-10-2018 |
Opleiding van Tirtha Chakraborty
| Tata Institute of Fundamental Research | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Zwitserland | 2 |
| India | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| VOR BIOPHARMA INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Commercial Services |
- Beurs
- Insiders
- Tirtha Chakraborty
- Ervaring